Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside
Kamal Kant Sahu, Ahmad Daniyal Siddiqui, Jan Černý
Laboratory Medicine (2020) Vol. 52, Iss. 1, pp. 24-35
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Role of Toll‐like receptors in the pathogenesis of COVID‐19
Shaghayegh Khanmohammadi, Nima Rezaei
Journal of Medical Virology (2021) Vol. 93, Iss. 5, pp. 2735-2739
Open Access | Times Cited: 316
Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era
Ángel Serrano‐Aroca, Kazuo Takayama, Alberto Tuñón-Molina, et al.
ACS Nano (2021) Vol. 15, Iss. 5, pp. 8069-8086
Open Access | Times Cited: 161
Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19
Dipak Kumar, Sadaf Jahan, Andleeb Khan, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 7, pp. 3417-3434
Open Access | Times Cited: 49
Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients
Morteza Shakhsi Niaee, Peyman Namdar, Abbas Allami, et al.
Asian Pacific Journal of Tropical Medicine (2021) Vol. 14, Iss. 6, pp. 266-273
Open Access | Times Cited: 48
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
Lijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 33
Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery
Pedro Silva Couto, Nada Al-Arawe, Igor Salerno Filgueiras, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials
Parichehr Hassanzadeh
Journal of Controlled Release (2020) Vol. 328, pp. 112-126
Open Access | Times Cited: 45
Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19
Dhavan Sharma, Feng Zhao
npj Regenerative Medicine (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 36
Role of 2-Deoxy-D-Glucose (2-DG) in COVID-19 disease
Kamal K. Sahu, Raman Kumar
Journal of Family Medicine and Primary Care (2021) Vol. 10, Iss. 10, pp. 3548-3552
Open Access | Times Cited: 33
Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects: Update from 2015 review
Leah A. Marquez‐Curtis, Janet A.W. Elliott
Cryobiology (2024) Vol. 115, pp. 104856-104856
Open Access | Times Cited: 4
Antimicrobial Peptides and Physical Activity: A Great Hope against COVID 19
Sonia Laneri, Mariarita Brancaccio, Cristina Mennitti, et al.
Microorganisms (2021) Vol. 9, Iss. 7, pp. 1415-1415
Open Access | Times Cited: 26
Efficacy and safety of mesenchymal stem cells therapy in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
Wenming Lu, Longxiang Yan, Xingkun Tang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Potential Cell-Based and Cell-Free Therapy for Patients with COVID-19
Marselina Irasonia Tan, Nayla Majeda Alfarafisa, Popi Septiani, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2319-2319
Open Access | Times Cited: 12
Mesenchymal stromal cells (MSCs) as a therapeutic agent of inflammatory disease and infectious COVID-19 virus: live or dead mesenchymal?
Ramiar Kamal Kheder, Omeed Darweesh, Bashdar Mahmud Hussen, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 2
Immune safety challenges facing the preclinical assessment and clinical progression of cell therapies
Stephanie M. Bates, Kelly V. Evans, Louise Delsing, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 12, pp. 104239-104239
Closed Access | Times Cited: 1
How to Make Sense out of 75,000 Mesenchymal Stromal Cell Publications?
Dina Mönch, Marlies E. J. Reinders, Marc H. Dahlke, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1419-1419
Open Access | Times Cited: 7
Potential role of biochemical markers in the prognosis of COVID-19 patients
Apeksha Niraula, Nirmal Baral, Madhab Lamsal, et al.
SAGE Open Medicine (2022) Vol. 10
Open Access | Times Cited: 6
Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19
Elham Zendedel, Lobat Tayebi, Mohammad Reza Nikbakht, et al.
Current Stem Cell Research & Therapy (2023) Vol. 19, Iss. 8, pp. 1055-1071
Closed Access | Times Cited: 3
Stem Cell Safety and Sterility Testing: A Promising Approach in Regenerative Medicine
Pankhi Vatsa, Sadaf Jahan, Uzair Ahmad Ansari, et al.
Springer eBooks (2022), pp. 205-232
Closed Access | Times Cited: 4
New perspective towards therapeutic regimen against SARS-CoV-2 infection
Vartika Srivastava, Aijaz Ahmad
Journal of Infection and Public Health (2021) Vol. 14, Iss. 7, pp. 852-862
Open Access | Times Cited: 5
The Role of Advanced Technologies against COVID-19: Prevention, Detection, and Treatments
Elham Hasanzadeh, Adele Rafati, Seyedeh Masoumeh Seyed Hosseini Tamijani, et al.
Current Stem Cell Research & Therapy (2022) Vol. 18, Iss. 6, pp. 800-828
Closed Access | Times Cited: 3
Nanotheronostics: Part II
Sikandar Shaikh
(2024), pp. 291-309
Closed Access
Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3.
Hamid Asadzadeh Aghdaei, Negar Jamshidi, Vahid Chaleshi, et al.
PubMed (2021) Vol. 14, Iss. 4, pp. 295-303
Closed Access | Times Cited: 2
Stem cell transplantation for COVID-19 management: Translational possibilities and future
Renjith P. Nair, P. Lekshmi, Sunitha Chandran
Elsevier eBooks (2022), pp. 139-151
Closed Access | Times Cited: 1
Investigation of Biochemical Blood Parameters of COVID-19 Patients Short (running) title: Biochemical Blood Parameters of COVID-19 Patients
Semih Eriten
Authorea (Authorea) (2023)
Open Access
Page 1 - Next Page

Scroll to top